JDK, a leading company in the development of pharmaceutical intermediates and basic chemicals, has recently announced the launch of a high-quality N-Acetyl-L-Tyrosine product. This new product is a re

JDK's Breakthrough in Developing New Pharmaceutical Intermediates In recent medical news, a breakthrough in the development of pharmaceutical intermediates has been announced. Vonoprazan Fumarate, a

JDK Introduces Vitamin K3 Msb 96% to its Line of Pharmaceutical Intermediates JDK, a leading company in the development of pharmaceutical intermediates and basic chemicals, has announced the addition

JDK, a leading pharmaceutical company with a focus on the development of pharmaceutical intermediates and basic chemicals, has recently introduced a groundbreaking product into the market. The company

ODM Glutamic Acid Supplied by Leading Pharmaceutical Intermediates and Basic Chemicals Company In recent years, the demand for pharmaceutical intermediates and basic chemicals has significantly incre

JDK, a leading company in the pharmaceutical and chemical industry, has announced the development of a breakthrough product - Polyethylene Glycol 6000. This product has the potential to revolutionize

JDK, a leading company in the development of pharmaceutical intermediates and basic chemicals, has made a significant breakthrough with the development of famous Dl(+)-Aspartic Acid. This groundbreaki

JDK, a renowned developer and supplier of pharmaceutical intermediates and basic chemicals, has recently made a significant breakthrough in the development of 4-Amino-3-Chlorophenol. This achievement

JDK Announces Breakthrough Development of New Pharmaceutical Intermediate In a recent announcement, JDK, a leading chemical company, has revealed their groundbreaking development of a new pharmaceuti

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has recently announced the development of a new pharmaceutical intermediate with the CAS No.